Form 4 Filing: Weng Dan Acquires (Grant) shares of $GYRE

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

GYRE THERAPEUTICS, INC.

Ticker: $GYRE

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-06-10

Shares: 40,000

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Weng Dan, holds the title of Director at GYRE THERAPEUTICS, INC..

On 2026-06-10, the insider transacted 40,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Weng Dan (Director) was granted $0 of $GYRE

Post-Transaction Position: 40,000 shares

SEC Accession No: 0001140361-26-027006 (CIK: 2083482)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$GYRE Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$GYRE News Coverage